Rory Collins created and led large studies that transformed statins from esoteric drugs for familial hypercholesterolaemia into safe, widely-used generics that annually prevent millions of heart attacks and ischaemic strokes. His large placebo-controlled trials and worldwide Cholesterol Treatment Trialists’ meta-analyses confirmed heart attack reduction, discovered stroke reduction, and demonstrated safety and efficacy in many different types of patient.
Nuffield Professor of Population Health, Nuffield Department of Population Health, University of Oxford
Interest and expertise
Health and human sciences
Clinical epidemiology, Medical statistics and demography, Medicine, clinical studies